<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39394550</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>A complex ePrescribing antimicrobial stewardship-based (ePAMS+) intervention for hospitals: mixed-methods feasibility trial results.</ArticleTitle><Pagination><StartPage>301</StartPage><MedlinePgn>301</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">301</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-024-02707-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antibiotic resistant infections cause over 700,000 deaths worldwide annually. As antimicrobial stewardship (AMS) helps minimise the emergence of antibiotic resistance resulting from inappropriate use of antibiotics in healthcare, we developed ePAMS+ (ePrescribing-based Anti-Microbial Stewardship), an ePrescribing and Medicines Administration (EPMA) system decision-support tool complemented by educational, behavioural and organisational elements.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a non-randomised before-and-after feasibility trial, implementing ePAMS+ in two English hospitals using the Cerner Millennium EPMA system. Wards of several specialties were included. Patient participants were blinded to whether ePAMS+ was in use; prescribers were not. A mixed-methods evaluation aimed to establish: acceptability and usability of ePAMS+ and trial processes; feasibility of ePAMS+ implementation and quantitative outcome recording; and a Fidelity Index measuring the extent to which ePAMS+ was delivered as intended. Longitudinal semi-structured interviews of doctors, nurses and pharmacists, alongside non-participant observations, gathered qualitative data; we extracted quantitative prescribing data from the EPMA system. Normal linear modelling of the defined daily dose (DDD) of antibiotic per admission quantified its variability, to inform sample size calculations for a future trial of ePAMS+ effectiveness.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The research took place during the SARS-CoV-2 pandemic, from April 2021 to November 2022. 60 qualitative interviews were conducted (33 before ePAMS+ implementation, 27 after). 1,958 admissions (1,358 before ePAMS+ implementation; 600 after) included 24,884 antibiotic orders. Qualitative interviews confirmed that some aspects of ePAMS+ , its implementation and training were acceptable, while other features (e.g. enabling combinations of antibiotics to be prescribed) required further development. ePAMS+ uptake was low (28 antibiotic review records from 600 admissions; 0.047 records per admission), preventing full development of a Fidelity Index. Normal linear modelling of antibiotic DDD per admission showed a residual variance of 1.086 (log-transformed scale). Unavailability of indication data prevented measurement of some outcomes (e.g. number of antibiotic courses per indication).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This feasibility trial encountered unforeseen circumstances due to contextual factors and a global pandemic, highlighting the need for careful adaptation of complex intervention implementations to the local setting. We identified key refinements to ePAMS+ to support its wider adoption in clinical practice, requiring further piloting before a confirmatory effectiveness trial.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ISRCTN Registry ISRCTN13429325, 24 March 2022.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weir</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-6494-4903</Identifier><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK. Christopher.Weir@ed.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinder</LastName><ForeName>Susan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8451-2027</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamestam</LastName><ForeName>Imad</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2873-3682</Identifier><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharp</LastName><ForeName>Rona</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ennis</LastName><ForeName>Holly</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heed</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Robin</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9044-4611</Identifier><AffiliationInfo><Affiliation>Institute for the Study of Science, Technology and Innovation, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cresswell</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6634-9537</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dogar</LastName><ForeName>Omara</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-7122-8403</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences, University of York, York, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontefract</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0344-4075</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lilford</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0634-984X</Identifier><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slee</LastName><ForeName>Ann</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9731-7041</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuter</LastName><ForeName>Antony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0646-5939</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beggs</LastName><ForeName>Jillian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7591-3256</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slight</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0339-846X</Identifier><AffiliationInfo><Affiliation>School of Pharmacy, Newcastle University, Newcastle, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9210-4082</Identifier><AffiliationInfo><Affiliation>Warwick Medical School, University of Warwick, Warwick, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7022-3056</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073602" MajorTopicYN="Y">Antimicrobial Stewardship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="Y">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055695" MajorTopicYN="N">Electronic Prescribing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="N">Decision Support Systems, Clinical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bacteriology</Keyword><Keyword MajorTopicYN="N">Decision support</Keyword><Keyword MajorTopicYN="N">Health informatics</Keyword><Keyword MajorTopicYN="N">Infectious diseases</Keyword><Keyword MajorTopicYN="N">Microbiology</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39394550</ArticleId><ArticleId IdType="pmc">PMC11470576</ArticleId><ArticleId IdType="doi">10.1186/s12911-024-02707-9</ArticleId><ArticleId IdType="pii">10.1186/s12911-024-02707-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O’Neill J. Review on antimicrobial resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations; 2014.</Citation></Reference><Reference><Citation>Goossens H, Ferech M, Vander Stichele R, Elseviers M, Group EP. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–87.</Citation><ArticleIdList><ArticleId IdType="pubmed">15708101</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–87.</Citation><ArticleIdList><ArticleId IdType="pubmed">26603922</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union. Stockholm: ESAC-Net surveillance data; 2017.</Citation></Reference><Reference><Citation>English surveillance programme for antimicrobial utilisation and resistance (ESPAUR): Report 2020 to 2021. London; 2021.</Citation></Reference><Reference><Citation>Rabbi F, Banfield L, Munir M, Chagla Z, Mayhew A, de Souza R. Overprescription of antibiotics for treating hospitalized COVID-19 patients: a systematic review &amp; meta-analysis. Heliyon. 2023;9(10):e20563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10590847</ArticleId><ArticleId IdType="pubmed">37876436</ArticleId></ArticleIdList></Reference><Reference><Citation>ESPAUR SSTF Implementation subgroup. Start Smart - Then Focus. London: Antimicrobial Stewardship Toolkit for English Hospitals; 2015.</Citation></Reference><Reference><Citation>Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart—Then Focus. J Antimicrob Chemother. 2012;67:i51–63.</Citation><ArticleIdList><ArticleId IdType="pubmed">22855879</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS England: Commissioning for Quality and Innovation (CQUIN) Guidance for 2017–2019. 10.National Institute for Health and Care Excellence Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. NICE guideline [NG15]. 2015.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. NICE guideline [NG15]. 2015</Citation></Reference><Reference><Citation>Cresswell K, Mozaffar H, Shah S, Sheikh A. Approaches to promoting the appropriate use of antibioticsthrough hospital electronic prescribing systems: a scoping review. Int J Pharm Pract. 2017;25:5–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">27198585</ArticleId></ArticleIdList></Reference><Reference><Citation>King A, Cresswell KM, Coleman JJ, Pontefract SK, Slee A, Williams R, Sheikh A. Investigating the ways in which health information technology can promote antimicrobial stewardship: a conceptual overview. J R Soc Med. 2017;110(8):320–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546659</ArticleId><ArticleId IdType="pubmed">28730922</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir CJ, Adamestam I, Sharp R, Ennis H, Heed A, Williams R, Cresswell K, Dogar O, Pontefract SK, Coleman J, et al. A complex ePrescribing-based anti-microbial stewardship (ePAMS+) intervention for hospitals combining technological and behavioural components: protocol for a feasibility trial. Pilot Feasibility Stud. 2023;9:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9883604</ArticleId><ArticleId IdType="pubmed">36709308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross ELA, Sivyer K, Islam J, Santillo M, Mowbray F, Peto TEA, Walker AS, Yardley L, Llewelyn MJ. Adaptation and implementation of the ARK (Antibiotic Review Kit) intervention to safely and substantially reduce antibiotic use in hospitals: a feasibility study. J Hosp Infect. 2019;103(3):268–75.</Citation><ArticleIdList><ArticleId IdType="pubmed">31394146</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann T, Glasziou P, Boutron I, Milne R, Perera R, Moher D, Altman D, Barbour V, Macdonald H, Johnston M, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ Open. 2014;348:g1687.</Citation><ArticleIdList><ArticleId IdType="pubmed">24609605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mureyi D, Cresswell K, Sivyer K, Heed A, Weir CJ, Adamestam I, Sharp R, Ennis H, Dogar O, Pontefract S et al: The development of a complex digital and behavioural Antimicrobial Stewardship intervention for hospitals in England. BMC Medical Informatics and Decision Making 2024 (under peer review). Preprint: 10.21203/rs.3.rs-3715230/v1</Citation></Reference><Reference><Citation>Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H, Jinks C. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52:1893–907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993836</ArticleId><ArticleId IdType="pubmed">29937585</ArticleId></ArticleIdList></Reference><Reference><Citation>Azungah T. Qualitative research: deductive and inductive approaches to data analysis. Qual Res J. 2018;18(4):383–400.</Citation></Reference><Reference><Citation>Joffe H, Yardley L. Content and thematic analysis. In: Marks DF, Yardley L, editors. Research Methods for Clinical and Health Psychology. London: SAGE Publications; 2003. p. 55–68.</Citation></Reference><Reference><Citation>Cresswell K, Williams R, Sheikh A. Developing and applying a formative evaluation framework for health information technology implementations: qualitative investigation. J Med Internet Res. 2020;22(6):e15068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315366</ArticleId><ArticleId IdType="pubmed">32519968</ArticleId></ArticleIdList></Reference><Reference><Citation>Our seasons https://www.metoffice.gov.uk/weather/learn-about/met-office-for-schools/other-content/other-resources/our-seasons Accessed 5 July 2024.</Citation></Reference><Reference><Citation>Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R, DeFrancesco C, Levesque C, Sharp DL, Ogedegbe G, et al. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol. 2005;73(5):852–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">16287385</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters DH, Tran NT, Adam T: Implementation research in health: a practical guide. Geneva; 2013.</Citation></Reference><Reference><Citation>Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA, group; obotPc: CONSORT,. statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2010;2016:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5154046</ArticleId><ArticleId IdType="pubmed">27965879</ArticleId></ArticleIdList></Reference><Reference><Citation>Operational Pressures Escalation Levels (OPEL) Framework 2023/24 https://www.england.nhs.uk/publication/operational-pressures-escalation-levels-opel-framework-2023-24/ Accessed 10 Jan 2024.</Citation></Reference><Reference><Citation>Ladenheim D, Cramp E, Patel N. Are current electronic prescribing systems facilitating antimicrobial stewardship in acute National Health Service Hospital Trusts in the East of England? J Hosp Infect. 2016;94(2):200–1.</Citation><ArticleIdList><ArticleId IdType="pubmed">27575656</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dort BA, Penm J, Ritchie A, Baysari MT. The impact of digital interventions on antimicrobial stewardship in hospitals: a qualitative synthesis of systematic reviews. J Antimicrob Chemother. 2022;77(7):1828–37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9244225</ArticleId><ArticleId IdType="pubmed">35388414</ArticleId></ArticleIdList></Reference><Reference><Citation>Cresswell K, Hinder S, Sheikh A, Pontefract S, Watson NW, Price D, Heed A, Coleman J, Ennis H, Beggs J, et al. ePrescribing-based antimicrobial stewardship practices in an English National Health Service Hospital: qualitative interview study among medical prescribers and pharmacists. JMIR Formative Res. 2023;7(1):e37863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10282906</ArticleId><ArticleId IdType="pubmed">37279044</ArticleId></ArticleIdList></Reference><Reference><Citation>Cresswell KM, Mozaffar H, Lee L, Williams R, Sheikh A. Workarounds to hospital electronic prescribing systems: a qualitative study in English hospitals. BMJ Qual Saf. 2017;26(7):542–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">27129493</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozaffar H, Cresswell KM, Williams R, Bates DW, Sheikh A. Exploring the roots of unintended safety threats associated with the introduction of hospital ePrescribing systems and candidate avoidance and/or mitigation strategies: a qualitative study. BMJ Qual Saf. 2017;26(9):722–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">28174319</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermanowicz JC. The longitudinal qualitative interview. Qual Sociol. 2013;36:189–208.</Citation></Reference><Reference><Citation>Dogar O, Boehnke J, Lorencatto F, Sheldon T, Siddiqi K. Measuring fidelity to behavioural support delivery for smoking cessation and its association with outcomes. Addiction. 2020;115:368–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7004188</ArticleId><ArticleId IdType="pubmed">31496033</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollock N, Williams R. Software and Organisations: The Biography of the Enterprise-Wide System - Or how SAP Conquered the World. Abingdon: Routledge; 2009.</Citation></Reference><Reference><Citation>https://bnf.nice.org.uk Accessed 26 Apr 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>